Corynebacterium (C.) macginleyi is a gram positive, lipophilic rod, usually considered a colonizer of skin and mucosal surfaces. Several reports have associated C. macginleyi with ocular infections, such as conjunctivitis and endophthalmitis. However, even if rare, extraocular infections from C. macginleyi may occur, especially among immunocompromised patients and patients with indwelling medical devices. We report herein the first case of surgical site infection by C. macginleyi after orthopaedic surgery for the correction of kyphoscoliosis in a patient with neurofibromatosis type 1. Our patient developed a nodular granulomatous lesion of about two centimetres along the surgical scar, at the level of C4-C5, with purulent discharge and formation of a fistulous tract. Cervical magnetic resonance imaging showed the presence of a two-centimetre fluid pocket in the subcutaneous tissue. Several swabs were collected from the borders of the lesion as well as from the exudate, with isolation of C. macginleyi. The isolate was susceptible to beta-lactams, cotrimoxazole, linezolid, and glycopeptides but resistant to quinolones, third-generation cephalosporins, and erythromycin. Two 30-day courses of antibiotic therapy with amoxicillin/clavulanate (1?g three times/day) and cotrimoxazole (800/160?mg twice a day) were administered, obtaining a complete healing of the lesion. 1. Introduction Corynebacterium (C.) macginleyi is a gram positive, lipophilic rod, first identified in 1995 by Riegel et al. [1]; as other nondiphtheria Corynebacterium species, commonly termed diphtheroids, it is usually considered a colonizer of skin and mucosal surfaces [2]. However, several reports have shown C. macginleyi to be associated with ocular infections, such as conjunctivitis and endophthalmitis [3, 4]. Nowadays, there is evidence that C. macginleyi may be responsible for extraocular infections in immunocompromised patients and patients with indwelling medical devices. In 2002, Villanueva et al. described the first case of nonconjunctival infection with C. macginleyi in an old man with a permanent bladder catheter and vesical stones [5]. Subsequent reports identified C. macginleyi as the causative agent of endocarditis [6, 7], septicaemia [8], and intravascular catheter-associated bloodstream infection [9, 10]. In a recent report of Dias et al., C. macginleyi was repeatedly isolated from tracheostomy secretions of a patient with laryngeal carcinoma [11]. We report herein the first case of surgical site infection by C. macginleyi after orthopaedic surgery for the correction of
References
[1]
P. Riegel, R. Ruimy, D. De Briel et al., “Genomic diversity and phylogenetic relationships among lipid-requiring diphtheroids from humans and characterization of Corynebacterium macginleyi sp. nov.,” International Journal of Systematic Bacteriology, vol. 45, no. 1, pp. 128–133, 1995.
[2]
K. J. McGinley, J. N. Labows, and J. M. Zechman, “Analysis of cellular components, biochemical reactions, and habitat of human cutaneous lipophilic diphtheroids,” Journal of Investigative Dermatology, vol. 85, no. 4, pp. 374–377, 1985.
[3]
A. M. Joussen, G. Funke, F. Joussen, and G. Herbertz, “Corynebacterium macginleyi: a conjunctiva specific pathogen,” British Journal of Ophthalmology, vol. 84, no. 12, pp. 1420–1422, 2000.
[4]
C. Ferrer, J. M. Ruiz-Moreno, A. Rodríguez, J. Montero, and J. L. Alió, “Postoperative Corynebacterium macginleyi endophthalmitis,” Journal of Cataract and Refractive Surgery, vol. 30, no. 11, pp. 2441–2444, 2004.
[5]
J. L. Villanueva, A. Domínguez, M. J. Ríos, and C. Iglesias, “Corynebacterium macginleyi isolated from urine in a patient with a permanent bladder catheter,” Scandinavian Journal of Infectious Diseases, vol. 34, no. 9, pp. 699–700, 2002.
[6]
M. Pubill Sucarrat, X. Martínez-Costa, G. Sauca Subías, and J. A. Capdevila Morell, “Corynebacterium macginleyi as an exceptional cause of endocarditis: a case report,” Anales de Medicina Interna, vol. 21, no. 1, pp. 44–45, 2004.
[7]
A. D. Tejada, “Endocarditis and aortic abscess due to Corynebacterium macginleyi,” Revista Clinica Espanola, vol. 207, no. 9, pp. 478–479, 2007.
[8]
I. Villamil-Cajoto, L. Rodríguez-Otero, M. J. Villacián-Vicedo et al., “Septicemia caused by Corynebacterium macginleyi: a rare form of extraocular infection,” International Journal of Infectious Diseases, vol. 12, no. 3, pp. 333–335, 2008.
[9]
G. Dobler and I. Braveny, “Highly resistant Corynebacterium macginleyi as cause of intravenous catheter-related infection,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 22, no. 1, pp. 72–73, 2003.
[10]
M. Mosele, N. Veronese, F. Bolzetta, E. Manzato, and G. Sergi, “A rare case of sepsis due to Corynebacterium macginleyi from central venous catheter in an elderly woman,” New Microbiologica, vol. 35, no. 1, pp. 89–91, 2012.
[11]
M. Dias, K. Shreevidya, S. D. Rao, and D. Shet, “Corynebacterium macginleyi a rare bacteria causing infection in an immunocompromised patient,” Journal of Cancer Research and Therapeutics, vol. 6, no. 3, pp. 374–375, 2010.
[12]
F. Campanile, E. Carretto, D. Barbarini et al., “Clonal multidrug-resistant Corynebacterium striatum strains, Italy,” Emerging Infectious Diseases, vol. 15, no. 1, pp. 75–78, 2009.
[13]
T. Suzuki, H. Iihara, T. Uno et al., “Suture-related keratitis caused by Corynebacterium macginleyi,” Journal of Clinical Microbiology, vol. 45, no. 11, pp. 3833–3836, 2007.
[14]
H. Eguchi, T. Kuwahara, T. Miyamoto et al., “High-level fluoroquinolone resistance in ophthalmic clinical isolates belonging to the species Corynebacterium macginleyi,” Journal of Clinical Microbiology, vol. 46, no. 2, pp. 527–532, 2008.